{
  "created_at": "Sat Sep 04 5:33:12 +0000 2021",
  "id_str": "1434012098674270208",
  "full_text": "Ivermectin’s rise parallels that of hydroxychloroquine, another much-touted “cure” for covid-19 https://t.co/HW1SXwtvUs",
  "display_text_range": [
    0,
    119
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/HW1SXwtvUs",
        "expanded_url": "https://econ.st/3n28QiM",
        "display_url": "econ.st/3n28QiM",
        "indices": [
          96,
          119
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 40,
  "favorite_count": 75,
  "possibly_sensitive": false,
  "original_created_at": "Sat Sep 04 04:35:01 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "イベルメクチンの増加は、コビド19 https://t.co/HW1SXwtvUs の「治療薬」として注目されているヒドロキシクロロキンの増加と類似している。"
    },
    {
      "locale": "zh",
      "full_text": "伊维菌素的崛起与另一种被大肆宣扬的 \"治愈 \"covid-19的药物--羟氯喹的崛起并行不悖 https://t.co/HW1SXwtvUs"
    },
    {
      "locale": "zh-Hant",
      "full_text": "伊維菌素的崛起與另一種被大肆宣揚的 \"治癒 \"covid-19的藥物--羥氯喹的崛起並行不悖 https://t.co/HW1SXwtvUs"
    }
  ]
}